{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:52:27Z","timestamp":1775065947582,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jns.2023.122857","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T21:38:59Z","timestamp":1703281139000},"page":"122857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history of stroke"],"prefix":"10.1016","volume":"456","author":[{"given":"Takehiro","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eijirou","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kishitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Kitaoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Nagakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jns.2023.122857_bb0005","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2023.122857_bb0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.jns.2023.122857_bb0015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.028","article-title":"Preceding antithrombotic treatment is associated with acute ischemic stroke severity and functional outcome at 90 days among patients with atrial fibrillation","volume":"28","author":"Yi","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.jns.2023.122857_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5551\/jat.46136","article-title":"Prestroke aspirin use is associated with clinical outcomes in ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke","volume":"26","author":"Lin","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.jns.2023.122857_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ijcp.12804","article-title":"Effect of prestroke antiplatelets use on first-ever ischaemic stroke severity and early outcome","volume":"70","author":"Bembenek","year":"2016","journal-title":"Int. J. Clin. Pract."},{"issue":"11","key":"10.1016\/j.jns.2023.122857_bb0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0000000000001361","article-title":"Prestroke antiplatelet agents in first-ever ischemic stroke: clinical effects","volume":"84","author":"Jung","year":"2015","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.jns.2023.122857_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/01.wnl.0000195889.05792.f1","article-title":"Premorbid antiplatelet use and ischemic stroke outcomes","volume":"66","author":"Sanossian","year":"2006","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jns.2023.122857_bb0040","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.36.7.1010-b","article-title":"Severity of stroke and aspirin","volume":"36","author":"Carolei","year":"1986","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.jns.2023.122857_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.35.5.632","article-title":"Does platelet antiaggregant therapy lessen the severity of stroke?","volume":"35","author":"Grotta","year":"1985","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.122857_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke."},{"issue":"1\u20132","key":"10.1016\/j.jns.2023.122857_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2011.02.006","article-title":"Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits","volume":"304","author":"Yamamoto","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2023.122857_bb0060","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/hs1201.099384","article-title":"Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST)","volume":"32","author":"Wilterdink","year":"2001","journal-title":"Stroke."},{"issue":"5\u20136","key":"10.1016\/j.jns.2023.122857_bb0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000443745","article-title":"Treatment with clopidogrel prior to acute non-cardioembolic ischemic stroke attenuates stroke severity","volume":"41","author":"Tziomalos","year":"2016","journal-title":"Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.jns.2023.122857_bb0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24602","article-title":"Comparative effectiveness of prestroke aspirin on stroke severity and outcome","volume":"79","author":"Park","year":"2016","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.122857_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1747-4949.2009.00331.x","article-title":"Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network","volume":"4","author":"Dowlatshahi","year":"2009","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.jns.2023.122857_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(92)90180-S","article-title":"Platelet activity and stroke severity","volume":"108","author":"Joseph","year":"1992","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2023.122857_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.011","article-title":"The interplay between stroke severity, antiplatelet use, and aspirin resistance in ischemic stroke","volume":"25","author":"Agayeva","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"3","key":"10.1016\/j.jns.2023.122857_bb0090","first-page":"133","article-title":"Effect of prior medical treatments on ischemic stroke severity and outcome","volume":"26","author":"Sacco","year":"2011","journal-title":"Funct. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2023.122857_bb0095","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/01.wnl.0000208406.45440.84","article-title":"Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk","volume":"66","author":"Kumar","year":"2006","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jns.2023.122857_bb0100","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/01.STR.0000226740.29910.91","article-title":"Previous use of aspirin and baseline stroke severity: an analysis of 17,850 patients in the International Stroke Trial","volume":"37","author":"Ricci","year":"2006","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.jns.2023.122857_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00415-006-0088-0","article-title":"Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke\/TIA","volume":"253","author":"Greisenegger","year":"2006","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2023.122857_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1052-3057(99)80050-0","article-title":"Stroke outcome in patients already taking aspirin","volume":"8","author":"Libman","year":"1999","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.jns.2023.122857_bb0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.53.4.825","article-title":"Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group","volume":"53","author":"Sivenius","year":"1999","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.122857_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-510X(96)00250-X","article-title":"Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirin","volume":"145","author":"De Keyser","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2023.122857_bb0125","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archneur.1997.00550230042014","article-title":"Does daily aspirin diminish severity of first-ever stroke?","volume":"54","author":"Karepov","year":"1997","journal-title":"Arch. Neurol."},{"issue":"10042","key":"10.1016\/j.jns.2023.122857_bb0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23023195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23023195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:05:53Z","timestamp":1758384353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23023195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":26,"alternative-id":["S0022510X23023195"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.122857","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history of stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.122857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122857"}}